Molecular diagnosis of lyme disease: Review and meta-analysis

Molecular Diagnosis

Volumn 6, Issue 1, 2001, Pages 1-11

  Dumler, J Stephen ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cerebrospinal fluid; Erythema migrans; PCR; Tick borne disease

Indexed keywords

ANTIBIOTIC AGENT; DNA; NUCLEIC ACID; PROTEIN;

BACTERIUM CULTURE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; CLINICAL TRIAL; DNA SEQUENCE; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOBLOTTING; INCIDENCE; IXODES; LYME DISEASE; META ANALYSIS; PLASMA; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN; SYNOVIAL FLUID; URINE;

EID: 0035081597     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1054/modi.2001.21898     Document Type: Article

References (87)

1. Factors in the emergence of infectious diseases
2. The biological and social phenomenon of Lyme disease
3. Surveillance for Lyme disease - United States, 1992-1998
4. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans
5. Neuroborreliosis
6. Management of Lyme arthritis
7. Muscle, reticuloendothelial, and late skin manifestations of Lyme disease
8. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi
9. Lyme arthritis: Lessons learned and to be learned
10. Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencephalomyelitides
11. Microbiology and laboratory diagnosis of tickborne diseases
12. Recommendations for test performance and interpretation for the Second National Conference on Serologic Diagnosis of Lyme disease
13. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 1
14. Laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 2
15. Effects of OspA vaccination on Lyme disease serologic testing
16. Improving the yield of blood cultures for patients with early Lyme disease
17. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
18. Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease
19. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions
20. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR
21. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis
22. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis
23. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
24. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis
25. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens
26. Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease
27. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis
28. The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids
29. Circulating Borrelia burgdorferi in patients with acute Lyme disease: Results of blood cultures and serum DNA analysis
30. Bloodstream invasion in early Lyme disease: Results from a prospective, controlled, blinded study using the polymerase chain reaction
31. Borrelia burgdorferi detected by culture and PCR in clinical relapse or disseminated borreliosis
32. Detection of Borrelia burgdorferi in biological samples using the polymerase chain reaction assay
33. Target imbalance: Disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients
34. The persistence of spirochetal nucleic acids in active Lyme arthritis
35. Polymerase chain reaction detection of Lyme disease: Correlation with clinical manifestations and serologic responses
36. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis
37. Detection of Borrelia burgdorferi sensu stricto by reverse line blot in the joints of Dutch patients with Lyme arthritis
38. Detection of Borrelia DNA in synovial fluid for diagnosis of Lyme arthritis
39. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis
40. Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction
41. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients
42. Detection of Borrelia burgdorferi DNA in urine samples and in cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction
43. Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of Lyme borreliosis agents in cerebrospinal fluid
44. Detection of Borrelia burgdorferi by nest polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis
45. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis
46. Evaluation of central nervous system involvements in Lyme borreliosis patients with a solitary erythema migrans lesion
47. Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis
48. Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy
49. Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis
50. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis
51. Diagnostic detection and direct genotyping of Borrelia burgdorferi by polymerase chain reactions in cerebrospinal fluid in Lyme neuroborreliosis
52. Effective use of polymerase chain reaction for diagnosis of central nervous system infections
53. Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease
54. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies
55. Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction
56. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy
57. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms
58. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions
59. Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction
60. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites
61. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic
62. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR
63. Quantitative detection of Borrelia burgdorferi by real-time PCR
64. Rapid differentiation of Borrelia garinii from Borrelia afzelii and Borrelia burgdorferi sensu stricto by LightCycler fluorescence melting curve analysis of a PCR product of the recA gene
65. Quantitative detection of Borrelia burgdorferi with a microtiter-based competitive polymerase chain reaction assay
66. Molecular typing of Borrelia burgdorferi sensu lato: Taxonomic, epidemiological, and clinical implications
67. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease
68. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans
69. Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi
70. Differentiation of Borrelia burgdorferi sensu lato on the basis of RNA polymerase gene (rpoB) sequences
71. Detection of Borrelia burgdorferi in patients with Lyme disease by the polymerase chain reaction
72. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis
73. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans
74. Lyme disease: Disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro
75. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease
76. Musculoskeletal manifestations of Lyme disease
77. Early disseminated Lyme disease: Lyme meningitis
78. Neuroborreliosis
79. The overdiagnosis of Lyme disease
80. A prospective study of tick bites in an endemic area for Lyme disease
81. Detection of B. burgdorferi in ticks by species-specific amplification of the flagellin gene
82. Use of polymerase chain reaction to detect bacteria in arthropods: A review
83. The value of early treatment of deer tick bites for the prevention of Lyme disease
84. Efficacy of antibiotic prophylaxis for prevention of Lyme disease
85. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks
86. Duration of tick bites in a Lyme disease-endemic area